It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate RD programs in several domains.
The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:
- Area of Expertise
- Cell Therapy
- Gene Therapy
- Scale of Operation
- Preclinical
- Clinical
- Drug Discovery
- Therapeutic Area
- Oncological Disorders
- Neurological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune Disorders
- Blood Disorders
- Rare / Genetic Disorders
- Ophthalmic Disorders
- Other disorders
- Analysis by Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
- Altasciences
- Charles River Laboratories
- Creative Biolabs
- IQVIA
- Medpace
- PPD
- Precision for Medicine
- Accelera
- Evotec
- ICON
- Syneos Health
- CMIC Group
- Labcorp
Table of Contents
- Preface
- Executive Summary
- Introduction
- Guide To Outsourcing
- Market Landscape
- Company Profiles
- Competitive Benchmarking
- Partnerships And Collaborations
- Mergers and Acquisitions
- Key Acquisition Targets
- Likely Partner Analysis for Cell Therapy CROs
- Likely Partner Analysis for Gene Therapy CROs
- Clinical Trial Analysis
- Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations
- Market Forecast and Opportunity Analysis
- Swot Analysis
- Conclusion
- Interview And Survey Transcripts
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
